Patents Examined by Rebecca E. Prouty
  • Patent number: 7939285
    Abstract: Disclosed is a convenent sample preparation method for a medium suspected of containing contaminants, the method comprising a) passing a known volume of said medium through a filter from an influent side to an effluent side thereby concentrating the contaminants on the influent side of the filter, b) contacting the influent side of the filter with a liquid vehicle containing at least one substrate that through interaction with the contaminants each produces a detectable moiety, c) and allowing the substrate to interact with the contaminants on the influent side of the filter for a period of time, which is sufficient to allow the detectable moiety to be detected in the liquid vehicle. The method may further comprise a detection step, where the amount of detectable is determined in the liquid vehicle, preferably after the liquid vehicle has been separated from the contaminant, e.g. by passing the liquid vehicle through the filter and performing a measurement on the contaminant free liquid vehicle.
    Type: Grant
    Filed: February 28, 2005
    Date of Patent: May 10, 2011
    Assignee: Mycometer APS
    Inventors: Morton Reeslev, Morten Miller
  • Patent number: 7932051
    Abstract: The present invention provides a test medium comprising a test microorganism, an indicator and a metal in ionized form, wherein the valence of said metal is at least 2 and the concentration of said metal is between 0.001 M and 1 M. Furthermore, there is provided a method for the determination of the presence of an antibiotic characterized in that a metal salt is added to said test medium and/or to said sample of fluid. Finally, there is provided a kit suitable for the determination of an antibiotic in a fluid.
    Type: Grant
    Filed: September 6, 2004
    Date of Patent: April 26, 2011
    Assignee: R-Biopharm AG
    Inventors: Edith Magda Lucia Geijp, Jacobus J. Stark
  • Patent number: 7923241
    Abstract: Disclosed is a cell culture article including: a substrate; a tie-layer attached to at least the substrate; and a bio-compatible layer attached to at least the tie layer, the bio-compatible layer having been obtained from surface oxidation of a polymer layer. Also disclosed are methods for making the cell culture article and methods for performing an assay of a ligand with the article.
    Type: Grant
    Filed: October 10, 2007
    Date of Patent: April 12, 2011
    Assignee: Corning Incorporated
    Inventors: Ye Fang, Paul E. Gagnon, Jr., Terry T. Goodrich, Joydeep Lahiri, John S. Peanasky, Hongming Wang, Jun Xi
  • Patent number: 7906325
    Abstract: The present invention relates to nucleic acids or nucleic acid fragments encoding amino acid sequences for fatty acid biosynthesis enzymes in plants, and the use thereof for the modification of, for example, fatty acid biosynthesis in plants. In particular, the present invention relates to nucleic acids or nucleic acid fragments encoding amino acid sequences of diacylglycerol acyltransferase enzymes.
    Type: Grant
    Filed: May 14, 2004
    Date of Patent: March 15, 2011
    Assignees: Agriculture Victoria Services Pty Ltd, AgResearch Limited
    Inventors: Gregory Thomas Bryan, Margaret Fiona Burling, Nicholas John Roberts, Alana Jean Trollope, Derek Ross Woodfield
  • Patent number: 7879617
    Abstract: A method for measuring the concentration of creatinine includes the steps of: (A) mixing a sample containing creatinine with a creatinine quantitative reagent including 1-methoxy-5-methylphenazinium in the absence of picric acid and any enzyme responsive to creatinine, to cause the creatinine to reduce the 1-methoxy-5-methylphenazinium; (B) electrochemically or optically measuring the amount of the 1-methoxy-5-methylphenazinium reduced in the step (A); and (C) determining the concentration of the creatinine contained in the sample from the amount of the reduced 1-methoxy-5-methylphenazinium measured in the step (B).
    Type: Grant
    Filed: January 6, 2010
    Date of Patent: February 1, 2011
    Assignee: Panasonic Corporation
    Inventors: Takahiro Nakaminami, Hiroaki Tachibana, Masato Suzuki
  • Patent number: 7879609
    Abstract: The invention provides compositions and methods related to human telomerase reverse transcriptase (hTRT), the catalytic protein subunit of human telomerase. The polynucleotides and polypeptides of the invention are useful for diagnosis, prognosis and treatment of human diseases, for changing the proliferative capacity of cells and organisms, and for identification and screening of compounds and treatments useful for treatment of diseases such as cancers.
    Type: Grant
    Filed: March 26, 2007
    Date of Patent: February 1, 2011
    Assignee: Geron Corporation
    Inventors: Gregg B. Morin, William H. Andrews
  • Patent number: 7879614
    Abstract: The invention relates to a simple screening test for neoplasia, a precancerous condition, or cancer of the breast. A method is described whereby a breast cancer marker is detected in breast fluid. In a particular embodiment, the method involves treating samples of breast fluids with an aldehyde detecting reagent without any prewashing. The appearance in breast fluids of a marker that is detected by an aldehyde detecting reagent, such as a Schiff's reagent, correlates very well with the disease status of the breast cancer subjects from which the fluids were obtained. Screening test kits are also provided.
    Type: Grant
    Filed: December 18, 2007
    Date of Patent: February 1, 2011
    Assignee: Dr. Susan Love Research Foundation
    Inventors: Jiri Jan Krepinsky, Rudolf Furrer, Ka Sing Yeung
  • Patent number: 7880021
    Abstract: 3-hydroxyflavone derivatives are useful in the detection and the quantification of cell apoptosis. Such derivatives are also useful as fluorescent probes in studying lipid asymmetry of cell plasma membrane and in detecting apopoptic cells. The derivatives can be used to monitor the evolution of diseases involving cell apoptosis.
    Type: Grant
    Filed: October 11, 2006
    Date of Patent: February 1, 2011
    Assignees: Centre National de la Recherche Scientifique (CNRS), Universite Louis Pasteur (Strasbourg I)
    Inventors: Yves Mely, Andrey Klymchenko, Oleksandr Demchenko, Vasyl Shynkar
  • Patent number: 7874128
    Abstract: A testing unit and a method of testing a sterilization packaging unit for microbial contamination of sterilized objects after they have been sterilized are disclosed. The testing unit includes a dry matrix for accommodating a nutrient medium and a receptacle containing a liquid. By applying the liquid onto the matrix, the matrix is provided with a nutrient medium. In the method, the testing unit is inserted into the sterilization packaging unit which is sterilized and stored. At a desired point in time, the receptacle is opened in order to produce the nutrient medium in the matrix. After a possible multiplication of microbes on the matrix, an observation of microbes takes place. The invention also relates to a sterilization packaging unit which has a rigid outer casing and is suitable for the application of the method.
    Type: Grant
    Filed: May 13, 2003
    Date of Patent: January 25, 2011
    Inventor: Hartmut Dunkelberg
  • Patent number: 7871791
    Abstract: A method for preparing a biofilm includes the steps of rinsing the biofilm. There is the step of staining the biofilm with potassium permanganate and water.
    Type: Grant
    Filed: January 18, 2007
    Date of Patent: January 18, 2011
    Assignee: Allegheny-Singer Research Institute
    Inventors: Luanne Hall-Stoodley, Paul Stoodley
  • Patent number: 7867722
    Abstract: A pretreatment agent for a sample to be subjected to Limulus assay comprising an alkali metal sulfate and/or an alkaline earth metal sulfate wherein the sulfate(s) has a final concentration of 20 mM or more when the sulfate(s) is allowed to contact with the sample, or an alkali metal halide and/or an alkaline earth metal halide wherein the halide(s) has a final concentration of from 0.4 M to 1.2 M or less when the halide(s) is allowed to contact with the sample, or a kit for Limulus assay reagent comprising thereof as a composing article.
    Type: Grant
    Filed: January 27, 2006
    Date of Patent: January 11, 2011
    Assignee: Seikagaku Corporation
    Inventors: Toshio Oda, Jun Aketagawa
  • Patent number: 7854705
    Abstract: An instrument for verification of presence of image enhancing, contrasting agent in a biopsy sample which was obtained by imaging the lesion area with an imaging modality which is sensitive to the contrasting agent. In one embodiment of the invention, an optical spectrometer is used to analyze biopsy samples for the presence of gadolinium enhanced Magnetic Resonance Imaging contrasting agent which typically pools in breast tumors.
    Type: Grant
    Filed: December 16, 2004
    Date of Patent: December 21, 2010
    Inventors: Olga Pawluczyk, Cameron Piron
  • Patent number: 7838531
    Abstract: Although it can be farnesylated, the mutant lamin A protein expressed in Hutchison Gilford Progeria Syndrome (HGPS) cannot be defarnesylated because the characteristic mutation causes deletion of a cleavage site necessary for binding the protease ZMPSTE24 and effecting defarnesylation. The result is an aberrant farnesylated protein (called “progerin”) that alters normal lamin A function as a dominant negative, as well as assuming its own aberrant function through its association with the nuclear membrane. The retention of farnesylation, and potentially other abnormal properties of progerin and other abnormal lamin gene protein products, produces disease. Farnesyltransferase inhibitors (FTIs) (both direct effectors and indirect inhibitors) will inhibit the formation of progerin, cause a decrease in lamin A protein, and/or an increase prelamin A protein. Decreasing the amount of aberrant protein improves cellular effects caused by and progerin expression.
    Type: Grant
    Filed: July 25, 2007
    Date of Patent: November 23, 2010
    Assignees: The United States of America as represented by the Department of Health and Human Services, The Regents of the University of Michiga, Progeria Research Foundation, Inc., The University of North Carolina at Chapel Hill
    Inventors: Leslie B. Gordon, Francis S. Collins, Thomas Glover, Michael W. Glynn, Brian C. Capell, Adrienne D. Cox, Channing J. Der
  • Patent number: 7833761
    Abstract: A microorganism is provided which has an ability to produce an L-amino acid such as L-lysine, L-tryptophan, L-phenylalanine, L-valine, L-leucine, L-isoleucine and L-serine, and has been modified to increase the activity of pyruvate synthase or pyruvate:NADP+ oxidoreductase. This microorganism is cultured in a medium containing ethanol or an aliphatic acid as the carbon source to produce and accumulate the L-amino acid in the medium or cells, and the L-amino acid is collected from the medium or the cells.
    Type: Grant
    Filed: September 2, 2008
    Date of Patent: November 16, 2010
    Assignee: Ajinomoto Co., Inc.
    Inventors: Masaru Terashita, Yoshihiro Usuda, Kazuhiko Matsui
  • Patent number: 7828968
    Abstract: A system for enumeration of cells in fluids by image cytometry is described for assessment of target populations such as leukocyte subsets in different bodily fluids or bacterial contamination in environmental samples, food products and bodily fluids. Briefly, fluorescently labeled target cells are linked to magnetic particles or beads. In one embodiment, a small, permanent magnet is inserted directly into the chamber containing the labeled cells. The magnets are coated with PDMS silicone rubber to provide a smooth and even surface which allows imaging on a single focal plane. The magnet is removed from the sample and illuminated with fluorescent light emitted by the target cells captured by a CCD camera. In another embodiment, a floater having a permanent magnet allows the target cells to line up along a single imaging plane within the sample solution.
    Type: Grant
    Filed: February 15, 2008
    Date of Patent: November 9, 2010
    Assignee: Veridex, LLC
    Inventors: Arjan G. J. Tibbe, Leon W. M. M. Terstappen
  • Patent number: 7820406
    Abstract: Functional oxygen-sensitive proteins are expressed in a heterologous diazotrophic cyanobacteria cell in the presence of ambient extracellular oxygen.
    Type: Grant
    Filed: September 2, 2005
    Date of Patent: October 26, 2010
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Alfred M. Spormann, Wing-On Ng
  • Patent number: 7820453
    Abstract: The present invention provides assays and kits for the screening of test compounds for their capability to induce cardiotoxicity in a subject. Said assays and kits are based on the finding that the interaction of astemizole with the HERG potassium channel can be exploited to predict cardiotoxicity of compounds during the development of new therapeutics and other agents.
    Type: Grant
    Filed: November 6, 2006
    Date of Patent: October 26, 2010
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Godelieve Irma Christine Maria Heylen, Cornelus Gerardus Maria Janssen, Mirek Jurzak, Henricus Petrus Martinus Maria Van Assouw
  • Patent number: 7816147
    Abstract: The illustrated embodiment comprises a biosensor utilizing plant cells and nutrient media for maintaining the plant cells in a live condition. A light source having desired optical characteristics is directed onto the plant cells and light spectra transmitted from the cells is detected by a photodetector. A controller analyzes signals from the photodetector to detect a state change in the plant cells in response to exposure to an agent.
    Type: Grant
    Filed: November 6, 2006
    Date of Patent: October 19, 2010
    Assignee: Hewlett-Packard Development Company, L.P.
    Inventor: Steven E. Carpenter
  • Patent number: 7811782
    Abstract: Methods and devices for applying hemodynamic patterns to human/animal cells in culture are described. Hemodynamic flow patterns are measured directly from the human circulation and translated to a motor that controls the rotation of a cone. The cone is submerged in fluid (i.e., cell culture media) and brought into close proximity to the cells. Rotation of the cone creates time-varying shear stresses. This model closely mimics the physiological hemodynamic forces imparted on endothelial cells in vivo. A TRANSWELL coculture dish (i.e., a coculture dish comprising an artificial porous membrane) may be incorporated, permitting two, three, or more different cell types to be physically separated within the culture dish environment. In-flow and out-flow tubing may be used to supply media, drugs, etc. separately and independently to both the inner and outer chambers. The physical separation of the cell types permits each cell type to be separately isolated for analysis.
    Type: Grant
    Filed: January 10, 2008
    Date of Patent: October 12, 2010
    Assignee: Hemoshear, LLC
    Inventors: Brett R. Blackman, Brian R. Wamhoff
  • Patent number: 7811803
    Abstract: Disclosed are methods for rapidly and efficiently purifying proteasomes using fusion proteins having homology to ubiquitin. Also disclosed are methods for assessing aberrant cell growth utilizing fusion proteins have homology to ubiquitin and a signal producing moiety.
    Type: Grant
    Filed: May 30, 2006
    Date of Patent: October 12, 2010
    Assignee: University of Medicine and Dentistry of New Jersey
    Inventor: Kiran Madura